Literature DB >> 8215042

Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors.

F A McMorris1, R L Mozell, M J Carson, Y Shinar, R D Meyer, N Marchetti.   

Abstract

In summary, our studies show that IGFs are potent regulators of oligodendrocyte development and myelination in vitro and in vivo. IGFs act at several levels: by promoting proliferation of oligodendrocytes and oligodendrocyte precursors, by inducing immature oligodendrocyte precursors to develop into oligodendrocytes, and by regulating myelin gene expression and the amount of myelin produced per oligodendrocyte. Our findings indicate that IGFs play a crucial role in normal oligodendrocyte development and myelination, and suggest that IGFs may have applications for the promotion of remyelination in myelin disorders such as MS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215042     DOI: 10.1111/j.1749-6632.1993.tb26247.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Body growth and brain development in premature babies: an MRI study.

Authors:  Loukia C Tzarouchi; Aikaterini Drougia; Anastasia Zikou; Paraskevi Kosta; Loukas G Astrakas; Styliani Andronikou; Maria I Argyropoulou
Journal:  Pediatr Radiol       Date:  2013-11-05

Review 2.  The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system.

Authors:  F Folli; S Ghidella; L Bonfanti; C R Kahn; A Merighi
Journal:  Mol Neurobiol       Date:  1996-10       Impact factor: 5.590

3.  Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

Authors:  S A Loddick; X J Liu; Z X Lu; C Liu; D P Behan; D C Chalmers; A C Foster; W W Vale; N Ling; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination.

Authors:  Martha Zeger; Greg Popken; Jihui Zhang; Shouhong Xuan; Q Richard Lu; Markus H Schwab; Klaus-Armin Nave; David Rowitch; A Joseph D'Ercole; Ping Ye
Journal:  Glia       Date:  2007-03       Impact factor: 7.452

Review 5.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

6.  Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: increased myelination and potential for studies on the effects of increased IGF-1 on experimentally and genetically induced demyelination.

Authors:  Paola Luzi; Mariam Zaka; Han Zhi Rao; Mark Curtis; Mohammad A Rafi; David A Wenger
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

7.  BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain.

Authors:  Melissa W Vondran; Patricia Clinton-Luke; Jean Z Honeywell; Cheryl F Dreyfus
Journal:  Glia       Date:  2010-05       Impact factor: 7.452

Review 8.  Expanding the mind: insulin-like growth factor I and brain development.

Authors:  A Joseph D'Ercole; Ping Ye
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

Review 9.  Astrocytes in multiple sclerosis: a product of their environment.

Authors:  A Nair; T J Frederick; S D Miller
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

10.  Insulin-like growth factor-1 regulation of retinal progenitor cell proliferation and differentiation.

Authors:  Yuyao Wang; Dandan Zhang; Yi Zhang; Ni Ni; Zhimin Tang; Zhisha Bai; Bingqiao Shen; Hao Sun; Ping Gu
Journal:  Cell Cycle       Date:  2018-04-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.